Target Name: ZNF736
NCBI ID: G728927
Review Report on ZNF736 Target / Biomarker Content of Review Report on ZNF736 Target / Biomarker
ZNF736
Other Name(s): Zinc finger protein 736, transcript variant 1 | ZN736_HUMAN | ZNF736 variant 1 | Zinc finger protein 736 (isoform 1) | FLJ43489 | KRAB-containing zinc-finger repressor protein | Zinc finger protein 736 | zinc finger protein 736 | hypothetical protein LOC644283

ZNF736: A Potential Drug Target and Biomarker for Inflammatory Neurodegenerative Diseases

The ZNF736 protein is a member of the Zinc Finger Protein (ZNF) family, which is a family of transmembrane proteins that contain a characteristic zinc finger motif. ZNF736 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and peripheral tissues. It plays a role in cell signaling, specifically in the regulation of inflammation and neurodegeneration. The ZNF736 gene has four splice variants, including transcript variant 1 (ZNF736-1), which is the most abundant and well-studied variant.

Inflammation is a crucial aspect of the immune system, but it can also be a contributing factor to the development and progression of various neurodegenerative diseases. Chronic inflammation can result in the activation and overgrowth of immune cells, which can cause damage to neural tissue and contribute to the development of neurodegeneration. Therefore, identifying potential drug targets and biomarkers for these diseases is of great interest.

ZNF736 as a Drug Target

The ZNF736 protein has been identified as a potential drug target for various inflammatory and neurodegenerative diseases. Several studies have shown that ZNF736 is involved in the regulation of inflammation and neurodegeneration, and that it can be used as a biomarker for these diseases.

First, ZNF736 has been shown to regulate the activity of immune cells, including T cells and macrophages. These immune cells are involved in the regulation of inflammation, and their activity can be modulated by various factors, including ZNF736. Studies have shown that ZNF736 can inhibit the activation and proliferation of T cells, and that it can also modulate the activity of macrophages.

Second, ZNF736 has been shown to be involved in the regulation of neurodegeneration. Neural tissue is delicate and sensitive to damage, and it is important to identify factors that contribute to neurodegeneration. Studies have shown that ZNF736 is involved in the regulation of neurogenesis, and that it can be used as a biomarker for neurodegenerative diseases.

Third, ZNF736 has been shown to be involved in the regulation of cell signaling. Signal transduction is a critical aspect of cell signaling, and it is important to identify factors that regulate signaling. Studies have shown that ZNF736 is involved in the regulation of cell signaling, and that it can be used as a potential drug target for diseases that are characterized by abnormal signaling.

Discussion

In conclusion, ZNF736 is a protein that has been identified as a potential drug target for various inflammatory and neurodegenerative diseases. ZNF736 has been shown to regulate the activity of immune cells, and it has also been shown to be involved in the regulation of neurodegeneration and cell signaling. Further research is needed to fully understand the role of ZNF736 in these diseases and to identify effective drug targets.

Conclusion

In conclusion, ZNF736 is a protein that has the potential to be a drug target for various inflammatory and neurodegenerative diseases. ZNF736 has been shown to regulate the activity of immune cells and it has also been shown to be involved in the regulation of neurodegeneration and cell signaling. Further research is needed to fully understand the role of ZNF736 in these diseases and to identify effective drug targets.

Protein Name: Zinc Finger Protein 736

Functions: May be involved in transcriptional regulation

The "ZNF736 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF736 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888